{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:51:08Z","timestamp":1793508668336,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010418","name":"Institute for Information and Communications Technology Promotion","doi-asserted-by":"publisher","award":["IITP-2021-0-02068, RS-2020-II201373, RS-2023-00220628"],"award-info":[{"award-number":["IITP-2021-0-02068, RS-2020-II201373, RS-2023-00220628"]}],"id":[{"id":"10.13039\/501100010418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00421203"],"award-info":[{"award-number":["RS-2024-00421203"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05645-2","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:55:58Z","timestamp":1751363758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Activated cancer-associated fibroblasts correlate with poor survival and decreased lymphocyte infiltration in infiltrative type distal cholangiocarcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Dae Hyun","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Kyun","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Kwan","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyueng-Whan","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoung Wan","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Jung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Soo","family":"Pyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonhyeong","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"5645_CR1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.6004\/jnccn.2017.7056","volume":"16","author":"SKR Mukkamalla","year":"2018","unstructured":"Mukkamalla, S. K. R., Naseri, H. M., Kim, B. M., Katz, S. C. & Armenio, V. A. Trends in incidence and factors affecting survival of patients with cholangiocarcinoma in the united States. J. Natl. Compr. Canc Netw. 16, 370\u2013376. https:\/\/doi.org\/10.6004\/jnccn.2017.7056 (2018).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"5645_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales, J. M. et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat. Rev. Gastroenterol. Hepatol. 17, 557\u2013588. https:\/\/doi.org\/10.1038\/s41575-020-0310-z (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"5645_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.clinre.2020.03.024","volume":"44","author":"MM Gad","year":"2020","unstructured":"Gad, M. M. et al. Epidemiology of cholangiocarcinoma; united States incidence and mortality trends. Clin. Res. Hepatol. Gastroenterol. 44, 885\u2013893. https:\/\/doi.org\/10.1016\/j.clinre.2020.03.024 (2020).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"5645_CR4","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/oncolo\/oyac150","volume":"27","author":"M Javle","year":"2022","unstructured":"Javle, M. et al. Temporal changes in cholangiocarcinoma incidence and mortality in the united States from 2001 to 2017. Oncologist 27, 874\u2013883. https:\/\/doi.org\/10.1093\/oncolo\/oyac150 (2022).","journal-title":"Oncologist"},{"key":"5645_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/01.sla.0000150166.94732.88","volume":"241","author":"JY Jang","year":"2005","unstructured":"Jang, J. Y. et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann. Surg. 241, 77\u201384. https:\/\/doi.org\/10.1097\/01.sla.0000150166.94732.88 (2005).","journal-title":"Ann. Surg."},{"key":"5645_CR6","doi-asserted-by":"publisher","first-page":"EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015","volume":"1","author":"DY Oh","year":"2022","unstructured":"Oh, D. Y. et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract Cancer. NEJM Evid. 1, EVIDoa2200015. https:\/\/doi.org\/10.1056\/EVIDoa2200015 (2022).","journal-title":"NEJM Evid."},{"key":"5645_CR7","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle, J. et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl. J. Med. 362, 1273\u20131281. https:\/\/doi.org\/10.1056\/NEJMoa0908721 (2010).","journal-title":"N Engl. J. Med."},{"key":"5645_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/jca.17648","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang, M. et al. Role of tumor microenvironment in tumorigenesis. J. Cancer. 8, 761\u2013773. https:\/\/doi.org\/10.7150\/jca.17648 (2017).","journal-title":"J. Cancer"},{"key":"5645_CR9","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1245\/s10434-009-0568-4","volume":"16","author":"H Okabe","year":"2009","unstructured":"Okabe, H. et al. Hepatic stellate cells May relate to progression of intrahepatic cholangiocarcinoma. Ann. Surg. Oncol. 16, 2555\u20132564. https:\/\/doi.org\/10.1245\/s10434-009-0568-4 (2009).","journal-title":"Ann. Surg. Oncol."},{"key":"5645_CR10","doi-asserted-by":"publisher","first-page":"16779","DOI":"10.1038\/s41598-021-96344-1","volume":"11","author":"KW Min","year":"2021","unstructured":"Min, K. W. et al. Cancer-associated fibroblasts are associated with poor prognosis in solid type of lung adenocarcinoma in a machine learning analysis. Sci. Rep. 11, 16779. https:\/\/doi.org\/10.1038\/s41598-021-96344-1 (2021).","journal-title":"Sci. Rep."},{"key":"5645_CR11","doi-asserted-by":"publisher","unstructured":"Garvey, C. M. et al. Anti-EGFR therapy induces EGF secretion by Cancer-Associated fibroblasts to confer colorectal Cancer chemoresistance. Cancers (Basel). 12 https:\/\/doi.org\/10.3390\/cancers12061393 (2020).","DOI":"10.3390\/cancers12061393"},{"key":"5645_CR12","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1038\/s41598-023-31416-y","volume":"13","author":"YA Nanehkaran","year":"2023","unstructured":"Nanehkaran, Y. A. et al. The predictive model for COVID-19 pandemic plastic pollution by using deep learning method. Sci. Rep. 13, 4126. https:\/\/doi.org\/10.1038\/s41598-023-31416-y (2023).","journal-title":"Sci. Rep."},{"key":"5645_CR13","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1245\/s10434-023-14715-6","volume":"31","author":"HS Kim","year":"2024","unstructured":"Kim, H. S. et al. Cancer-Associated fibroblasts together with a decline in CD8\u2009+\u2009T cells predict a worse prognosis for breast Cancer patients. Ann. Surg. Oncol. 31, 2114\u20132126. https:\/\/doi.org\/10.1245\/s10434-023-14715-6 (2024).","journal-title":"Ann. Surg. Oncol."},{"key":"5645_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/bioinformatics\/btu684","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L. G., Yan, G. R. & He, Q. Y. DOSE: an r\/bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics 31, 608\u2013609. https:\/\/doi.org\/10.1093\/bioinformatics\/btu684 (2015).","journal-title":"Bioinformatics"},{"key":"5645_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/c5mb00663e","volume":"12","author":"G Yu","year":"2016","unstructured":"Yu, G. & He, Q. Y. ReactomePA: an r\/bioconductor package for reactome pathway analysis and visualization. Mol. Biosyst. 12, 477\u2013479. https:\/\/doi.org\/10.1039\/c5mb00663e (2016).","journal-title":"Mol. Biosyst"},{"key":"5645_CR16","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/biom.12868","volume":"74","author":"S Huang","year":"2018","unstructured":"Huang, S. et al. Regularized continuous-time Markov model via elastic net. Biometrics 74, 1045\u20131054. https:\/\/doi.org\/10.1111\/biom.12868 (2018).","journal-title":"Biometrics"},{"key":"5645_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fnbot.2013.00021","volume":"7","author":"A Natekin","year":"2013","unstructured":"Natekin, A. & Knoll, A. Gradient boosting machines, a tutorial. Front. Neurorobot. 7, 21. https:\/\/doi.org\/10.3389\/fnbot.2013.00021 (2013).","journal-title":"Front. Neurorobot"},{"key":"5645_CR18","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang, W. et al. Genomics of drug sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41, D955\u2013961. https:\/\/doi.org\/10.1093\/nar\/gks1111 (2013).","journal-title":"Nucleic Acids Res."},{"key":"5645_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","volume":"91","author":"S Bamford","year":"2004","unstructured":"Bamford, S. et al. The COSMIC (Catalogue of somatic mutations in Cancer) database and website. Br. J. Cancer. 91, 355\u2013358. https:\/\/doi.org\/10.1038\/sj.bjc.6601894 (2004).","journal-title":"Br. J. Cancer"},{"key":"5645_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri, R. The biology and function of fibroblasts in cancer. Nat. Rev. Cancer. 16, 582\u2013598. https:\/\/doi.org\/10.1038\/nrc.2016.73 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"5645_CR21","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/cyto.a.23101","volume":"93","author":"Z Kahounova","year":"2018","unstructured":"Kahounova, Z. et al. The fibroblast surface markers FAP, anti-fibroblast, and FSP are expressed by cells of epithelial origin and May be altered during epithelial-to-mesenchymal transition. Cytometry A. 93, 941\u2013951. https:\/\/doi.org\/10.1002\/cyto.a.23101 (2018).","journal-title":"Cytometry A"},{"key":"5645_CR22","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.bbadis.2017.07.028","volume":"1864","author":"M Cadamuro","year":"2018","unstructured":"Cadamuro, M. et al. The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma. Biochim. Biophys. Acta Mol. Basis Dis. 1864, 1435\u20131443. https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.028 (2018).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"5645_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/bs.acr.2022.01.009","volume":"156","author":"A Ravichandra","year":"2022","unstructured":"Ravichandra, A., Bhattacharjee, S. & Affo, S. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance. Adv. Cancer Res. 156, 201\u2013226. https:\/\/doi.org\/10.1016\/bs.acr.2022.01.009 (2022).","journal-title":"Adv. Cancer Res."},{"key":"5645_CR24","first-page":"12","volume":"12","author":"M Wetzel","year":"2019","unstructured":"Wetzel, M., Strickley, J., Haeberle, M. T. & Brown, T. S. Depth of invasion of aggressive and nonaggressive basal cell carcinoma. J. Clin. Aesthet. Dermatol. 12, 12\u201314 (2019).","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"5645_CR25","doi-asserted-by":"publisher","first-page":"1352632","DOI":"10.3389\/fimmu.2024.1352632","volume":"15","author":"A Kraxner","year":"2024","unstructured":"Kraxner, A. et al. Investigating the complex interplay between fibroblast activation protein alpha-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy. Front. Immunol. 15, 1352632. https:\/\/doi.org\/10.3389\/fimmu.2024.1352632 (2024).","journal-title":"Front. Immunol."},{"key":"5645_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.14336\/AD.2023.0420","volume":"15","author":"J Yan","year":"2024","unstructured":"Yan, J. et al. Cancer-Associated fibroblasts promote lymphatic metastasis in cholangiocarcinoma via the PDGF-BB\/PDGFR-beta mediated paracrine signaling network. Aging Dis. 15, 369\u2013389. https:\/\/doi.org\/10.14336\/AD.2023.0420 (2024).","journal-title":"Aging Dis."},{"key":"5645_CR27","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3892\/or_00000309","volume":"21","author":"C Chuaysri","year":"2009","unstructured":"Chuaysri, C. et al. Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma. Oncol. Rep. 21, 957\u2013969. https:\/\/doi.org\/10.3892\/or_00000309 (2009).","journal-title":"Oncol. Rep."},{"key":"5645_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/s1542-3565(04)00674-3","volume":"3","author":"A Caporale","year":"2005","unstructured":"Caporale, A. et al. Is desmoplasia a protective factor for survival in patients with colorectal carcinoma? Clin. Gastroenterol. Hepatol. 3, 370\u2013375. https:\/\/doi.org\/10.1016\/s1542-3565(04)00674-3 (2005).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"5645_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fcell.2018.00098","volume":"6","author":"M Haro","year":"2018","unstructured":"Haro, M. & Orsulic, S. A. Paradoxical correlation of Cancer-Associated fibroblasts with survival outcomes in B-Cell lymphomas and carcinomas. Front. Cell. Dev. Biol. 6, 98. https:\/\/doi.org\/10.3389\/fcell.2018.00098 (2018).","journal-title":"Front. Cell. Dev. Biol."},{"key":"5645_CR30","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","volume":"9","author":"A Chakravarthy","year":"2018","unstructured":"Chakravarthy, A., Khan, L., Bensler, N. P., Bose, P. & De Carvalho, D. D. TGF-beta-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure. Nat. Commun. 9, 4692. https:\/\/doi.org\/10.1038\/s41467-018-06654-8 (2018).","journal-title":"Nat. Commun."},{"key":"5645_CR31","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/hep.26585","volume":"58","author":"A Claperon","year":"2013","unstructured":"Claperon, A. et al. Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor. Hepatology 58, 2001\u20132011. https:\/\/doi.org\/10.1002\/hep.26585 (2013).","journal-title":"Hepatology"},{"key":"5645_CR32","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1158\/1078-0432.CCR-15-0715","volume":"22","author":"F Sabbatino","year":"2016","unstructured":"Sabbatino, F. et al. PD-L1 and HLA class I antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma. Clin. Cancer Res. 22, 470\u2013478. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0715 (2016).","journal-title":"Clin. Cancer Res."},{"key":"5645_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1091\/mbc.5.2.193","volume":"5","author":"AM Gardner","year":"1994","unstructured":"Gardner, A. M., Vaillancourt, R. R., Lange-Carter, C. A. & Johnson, G. L. MEK-1 phosphorylation by MEK kinase, raf, and mitogen-activated protein kinase: analysis of phosphopeptides and regulation of activity. Mol. Biol. Cell. 5, 193\u2013201. https:\/\/doi.org\/10.1091\/mbc.5.2.193 (1994).","journal-title":"Mol. Biol. Cell."},{"key":"5645_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00210-011-0637-7","volume":"384","author":"M Galuppo","year":"2011","unstructured":"Galuppo, M. et al. MEK Inhibition suppresses the development of lung fibrosis in the bleomycin model. Naunyn Schmiedebergs Arch. Pharmacol. 384, 21\u201337. https:\/\/doi.org\/10.1007\/s00210-011-0637-7 (2011).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"5645_CR35","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1038\/s41598-024-52359-y","volume":"14","author":"J Lee","year":"2024","unstructured":"Lee, J., Honjo, M. & Aihara, M. A MEK inhibitor arrests the cell cycle of human conjunctival fibroblasts and improves the outcome of glaucoma filtration surgery. Sci. Rep. 14, 1871. https:\/\/doi.org\/10.1038\/s41598-024-52359-y (2024).","journal-title":"Sci. Rep."},{"key":"5645_CR36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3892\/mmr.2018.9673","volume":"19","author":"J Wen","year":"2019","unstructured":"Wen, J. et al. MEK Inhibition prevents TGF\u2013beta1\u2013induced myofibroblast transdifferentiation in human tenon fibroblasts. Mol. Med. Rep. 19, 468\u2013476. https:\/\/doi.org\/10.3892\/mmr.2018.9673 (2019).","journal-title":"Mol. Med. Rep."},{"key":"5645_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10557-023-07428-1","volume":"38","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Mitogen-Activated protein kinases mediate adventitial fibroblast activation and Neointima formation via GATA4\/Cyclin D1 Axis. Cardiovasc. Drugs Ther. 38, 527\u2013538. https:\/\/doi.org\/10.1007\/s10557-023-07428-1 (2024).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"5645_CR38","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1158\/1078-0432.CCR-15-2851","volume":"23","author":"HM Brechbuhl","year":"2017","unstructured":"Brechbuhl, H. M. et al. Fibroblast subtypes regulate responsiveness of luminal breast Cancer to Estrogen. Clin. Cancer Res. 23, 1710\u20131721. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2851 (2017).","journal-title":"Clin. Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05645-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05645-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05645-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T21:03:44Z","timestamp":1751749424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05645-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5645"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05645-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5957452\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"20644"}}